blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3554534

EP3554534 - INSULIN CONTAINING PHARMACEUTICAL COMPOSITIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.04.2022
Database last updated on 26.04.2025
FormerThe patent has been granted
Status updated on  21.05.2021
FormerGrant of patent is intended
Status updated on  13.01.2021
FormerRequest for examination was made
Status updated on  20.11.2020
FormerGrant of patent is intended
Status updated on  21.07.2020
FormerRequest for examination was made
Status updated on  20.09.2019
FormerThe international publication has been made
Status updated on  23.06.2018
Formerunknown
Status updated on  03.02.2018
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT
published on 16.10.2024  [2024/42]
Applicant(s)For all designated states
Novo Nordisk A/S
Novo Allé
2880 Bagsværd / DK
[2019/43]
Inventor(s)01 / NORRMAN, Mathias
Novo Allé
2880 Bagsværd / DK
02 / HOSTRUP, Susanne
Novo Allé
2880 Bagsværd / DK
03 / STEENSGAARD, Dorte, Bjerre
Novo Allé
2880 Bagsværd / DK
04 / STRAUSS, Holger, Martin
Novo Allé
2880 Bagsværd / DK
05 / HANSEN, Rosa, Rebecca, Erritzøe
Novo Allé
2880 Bagsværd / DK
06 / HAVELUND, Svend
Novo Allé
2880 Bagsværd / DK
07 / SCHLEIN, Morten
Novo Allé
2880 Bagsværd / DK
08 / PEDERSEN, Jesper, Søndergaard
Novo Allé
2880 Bagsværd / DK
 [2019/43]
Application number, filing date17832941.315.12.2017
[2019/43]
WO2017EP83013
Priority number, dateEP2016020468816.12.2016         Original published format: EP 16204688
[2019/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018109162
Date:21.06.2018
Language:EN
[2018/25]
Type: A1 Application with search report 
No.:EP3554534
Date:23.10.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 21.06.2018 takes the place of the publication of the European patent application.
[2019/43]
Type: B1 Patent specification 
No.:EP3554534
Date:23.06.2021
Language:EN
[2021/25]
Search report(s)International search report - published on:EP21.06.2018
ClassificationIPC:A61K38/28, A61P5/48, A61K33/30, A61K47/10
[2020/29]
CPC:
A61K38/28 (EP,CN,IL,KR,RU,US); A61K38/26 (CN,IL,KR); A61K47/02 (EP,CN,IL,KR,RU,US);
A61K47/10 (CN,IL,KR,RU,US); A61K9/0019 (EP,CN,IL,KR); A61P3/00 (CN,IL,RU);
A61P3/04 (CN,IL); A61P3/06 (CN,IL); A61P3/10 (CN,IL,KR);
A61P43/00 (CN,IL,RU); A61P5/48 (EP,CN,IL,US) (-)
C-Set:
A61K38/26, A61K2300/00 (CN);
A61K38/28, A61K2300/00 (CN);
A61K38/28, A61K38/26 (EP)
Former IPC [2019/43]A61K38/28
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/43]
Extension statesBANot yet paid
MENot yet paid
Validation statesMA16.07.2019
TN16.07.2019
TitleGerman:INSULINHALTIGE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN[2019/43]
English:INSULIN CONTAINING PHARMACEUTICAL COMPOSITIONS[2019/43]
French:COMPOSITIONS PHARMACEUTIQUES CONTENANT DE L'INSULINE[2019/43]
Entry into regional phase16.07.2019National basic fee paid 
16.07.2019Designation fee(s) paid 
16.07.2019Examination fee paid 
Examination procedure16.07.2019Examination requested  [2019/43]
16.07.2019Date on which the examining division has become responsible
30.01.2020Amendment by applicant (claims and/or description)
22.07.2020Communication of intention to grant the patent
20.11.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
14.01.2021Communication of intention to grant the patent
11.05.2021Fee for grant paid
11.05.2021Fee for publishing/printing paid
11.05.2021Receipt of the translation of the claim(s)
Divisional application(s)EP20208962.9  / EP3821905
Opposition(s)24.03.2022No opposition filed within time limit [2022/22]
Fees paidRenewal fee
02.01.2020Renewal fee patent year 03
11.01.2021Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL23.06.2021
CY23.06.2021
EE23.06.2021
LT23.06.2021
LV23.06.2021
MC23.06.2021
MK23.06.2021
MT23.06.2021
SM23.06.2021
IS23.10.2021
LU15.12.2021
[2024/42]
Former [2024/23]AL23.06.2021
CY23.06.2021
EE23.06.2021
LT23.06.2021
LV23.06.2021
MC23.06.2021
MK23.06.2021
SM23.06.2021
IS23.10.2021
LU15.12.2021
Former [2023/30]AL23.06.2021
CY23.06.2021
EE23.06.2021
LT23.06.2021
LV23.06.2021
MC23.06.2021
SM23.06.2021
IS23.10.2021
LU15.12.2021
Former [2022/46]AL23.06.2021
EE23.06.2021
LT23.06.2021
LV23.06.2021
MC23.06.2021
SM23.06.2021
IS23.10.2021
LU15.12.2021
Former [2022/33]AL23.06.2021
EE23.06.2021
LT23.06.2021
LV23.06.2021
MC23.06.2021
SM23.06.2021
IS23.10.2021
Former [2022/26]AL23.06.2021
EE23.06.2021
LT23.06.2021
LV23.06.2021
SM23.06.2021
IS23.10.2021
Former [2022/11]EE23.06.2021
LT23.06.2021
LV23.06.2021
SM23.06.2021
IS23.10.2021
Former [2022/07]LT23.06.2021
LV23.06.2021
SM23.06.2021
Former [2021/49]LT23.06.2021
LV23.06.2021
Former [2021/46]LT23.06.2021
Cited inInternational search[AD]WO2009115469  (NOVO NORDISK AS [DK], et al);
 [AD]WO2013153000  (NOVO NORDISK AS [DK]);
 [A]WO2015052088  (NOVO NORDISK AS [DK])
by applicantWO2006097537
 WO2009063072
 WO2009115469
 WO2013153000
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.